SCHEMBL6362575

SCHEMBL6362575

Cc1ncc2c(-c3ccc(F)cc3)csc2n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.46
ALDH1A1 P00352 3/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
RAB9A P51151 3/20 0.43
CYP17A1 P05093 2/20 0.42
HPGD P15428 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
SIRT5 Q9NXA8 1/20 0.41
TP53 P04637 2/20 0.39
MEN1 O00255 2/20 0.38
HTT P42858 2/20 0.38
KMT2A Q03164 2/20 0.38
MAPT P10636 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
MITF O75030 1/20 0.38
STAT3 P40763 1/20 0.38
STAT1 P42224 1/20 0.38
PAX8 Q06710 1/20 0.38
PIP4K2C Q8TBX8 1/20 0.38
GRM5 P41594 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30341175 0.84 ALDH1A1 (0.46) LMNAALDH1A1SMN1; SMN2RAB9ACYP17A1
SCHEMBL14965544 0.81 ALDH1A1 (0.52) LMNAALDH1A1SMN1; SMN2RAB9ACYP17A1
SCHEMBL2368808 0.74 LMNA (0.55) LMNAALDH1A1SMN1; SMN2RAB9ACYP17A1
SCHEMBL2368929 0.73 LMNA (0.61) LMNAALDH1A1SMN1; SMN2RAB9AHPGD
SCHEMBL2368780 0.73 ALDH1A1 (0.40) LMNAALDH1A1SMN1; SMN2RAB9ACYP17A1
SCHEMBL27094473 0.72 ALDH1A1 (0.49) LMNAALDH1A1SMN1; SMN2RAB9AHPGD
SCHEMBL7215179 0.69 MAPK14 (0.56) MAPK14
SCHEMBL13527777 0.69 SMN1; SMN2 (0.68) LMNAALDH1A1SMN1; SMN2RAB9ACYP17A1
SCHEMBL16806037 0.66 MAPK14 (0.45) CYP17A1MAPTL3MBTL1MAPK14
SCHEMBL30341183 0.66 NPC1 (0.47) LMNAALDH1A1SMN1; SMN2RAB9AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050026935-A1 Compounds XENTION DISCOVERY LTD. 2005-02-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050026935-A1 Compounds KCNJ11, KCNJ1, KCNH1 LMNA 1126/4885ALDH1A1 247/4885SMN1; SMN2 1520/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.